MENU
+Compare
ARSUF
Stock ticker: OTC
AS OF
Sep 26 closing price
Price
$23.50
Change
-$0.16 (-0.68%)
Capitalization
1.72B

ARSUF Fagron SA Forecast, Technical & Fundamental Analysis

Fagron SA is a pharmaceutical compounding company operating in Belgium... Show more

ARSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ARSUF with price predictions
Nov 18, 2025

ARSUF's Indicator enters downward trend

The Aroon Indicator for ARSUF entered a downward trend on October 30, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 87 similar instances where the Aroon Indicator formed such a pattern. In of the 87 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.957) is normal, around the industry mean (18.491). P/E Ratio (17.294) is within average values for comparable stocks, (71.901). ARSUF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.834). Dividend Yield (0.017) settles around the average of (0.030) among similar stocks. P/S Ratio (1.607) is also within normal values, averaging (55.234).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARSUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARSUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ARSUF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

ARSUF paid dividends on May 19, 2021

Fagron SA ARSUF Stock Dividends
А dividend of $0.18 per share was paid with a record date of May 19, 2021, and an ex-dividend date of May 17, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Fascinatio Boulevard 350
Phone
+31 883311288
Employees
3567
Web
https://www.fagron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOEMX14.61N/A
N/A
Northern Emerging Markets Equity Index
VPCCX41.20N/A
N/A
Vanguard PRIMECAP Core Inv
LBGCX36.64N/A
N/A
ClearBridge Mid Cap Growth C
EISVX30.75N/A
N/A
Carillon ClariVest Intl Stock R6
QMGRX13.11-0.13
-0.98%
Invesco Advantage International R

ARSUF and Stocks

Correlation & Price change

A.I.dvisor tells us that ARSUF and CRDL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARSUF and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
CRDL - ARSUF
22%
Poorly correlated
+5.10%
AVCNF - ARSUF
12%
Poorly correlated
+9.38%
BSPK - ARSUF
2%
Poorly correlated
+11.11%
BIOGY - ARSUF
2%
Poorly correlated
N/A
PRFX - ARSUF
2%
Poorly correlated
-5.30%
More

Groups containing ARSUF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARSUF
1D Price
Change %
ARSUF100%
N/A
Pharmaceuticals: Generic
industry (214 stocks)
2%
Poorly correlated
-0.69%